Systematic Review: Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer. SPECIALTIES, 14 Mar 2022 Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer – Cochrane…